期刊文献+

半巢式聚合酶链反应方法检测弥漫性大B细胞淋巴瘤bcl-2/IgH基因重排 被引量:1

Detection of bcl-2/IgH gene rearrangement in diffuse large B cell lymphoma by hemi-nested PCR
原文传递
导出
摘要 目的寻找一种敏感、特异的方法检测弥漫性大B细胞淋巴瘤(DLBCL)bcl-2/IgH基因重排,并通过测定产物的序列,以了解所建方法的可靠性。方法运用专业引物设计软件设计bcl-2/IgH基因重排半巢式PCR引物,对52例经临床病理确诊的DLBCL石蜡包埋组织及10例慢性扁桃体炎患者的新鲜扁桃体组织通过半巢式递降温度梯度PCR(touch down PCR)扩增,检测bcl-2/IgH基因重排,并对其产物进行克隆和序列分析。结果通过一步法检测到bcl-2/IgH基因重排8例,其中DLBCL6例,新鲜扁桃体组织2例;进行第2次半巢式PCR时仅在DLBCL中发现5例阳性,新鲜扁桃体组织均阴性。将阳性产物在网上序列分析显示:一步法检测到的8例中有3例为假阳性,而半巢式PCR扩增出的5例均为bcl-2/IgH基因重排片段。3例假阳性的片段分别与人类第19号染色体BAC331191,LLNLR-245D11基因片段及1号染色体RP11-498P10基因片段同源。结论常用的检测bcl-2/IgH基因重排引物扩增结果存在一定假阳性,其机制可能是因为人类基因组中存在与常用引物同源性较高的序列。为研究设计的引物与传统的引物结合,进行半巢式PCR可以排除这种假阳性扩增,提高诊断的准确性。 Objectives To explore a sensitive and specific method for detection of bcl-2/IgH gene rearrangement in diffuse large B cell lymphoma(DLBCL) , and verify the credibility of the established method. Methods bcl-2/IgH hemi-nested PCR primers were designed using the professional primer design software. Fifty-two samples of pathologically diagnosed DLBCL and 10 fresh tonsil tissues were amplified using hemi-nested touch down-PCR to detect bcl-2/IgH gene rearrangement. The PCR products were cloned and sequenced. Results bcl-2/IgH gene rearrangement was detected in 6 of 52 DLBCL samples and 2 of 10 fresh tonsil tissues using one-way method. By using the hemi-nested PCR for the second round amplification, 5 of DLBCL were positive, but all of the fresh tonsil tissues were negative. The positive PCR products were sequenced and analyzed on the lnternet, 3 of 8 cases obtained by one-way method were false positive, 5 positive cases amplified using hemi-nested PCR were all bcl-2/IgH gene rearrangement. PCR products of 3 false positive cases were homologous to BAC331191 and LLNLR-245D11 in human chromosome 19 and RP11-498P10 in chromosome 1. Conclusion There are false positive results using common primers for detecting bcl-2/IgH gene rearrangement. The mechanism may be that highly homological sequences to human genome exist in eommonlv used primers. The specificity of the diagnosis could be improved by hemi-nested PCR using the combination of primers we designed and the traditional ones.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2005年第10期589-592,共4页 Chinese Journal of Hematology
基金 广东省社会发展攻关基金资助项目(B30301) 广州市科技计划基金资助项目(2002Z34061)
关键词 淋巴瘤 大细胞 弥漫型 基因 bcl-2 基因重排 聚合酶链反应 弥漫性大B细胞淋巴瘤 IGH基因重排 半巢式PCR Lymphoma, large-cell, diffuse Gene, bcl-2 Gene rearrangement Polymerase chain reaction
  • 相关文献

参考文献12

  • 1Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t( 14; 18 ) chromosome translocation. Science, 1984, 226:1097-1099.
  • 2Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol, 1994,124:1-6.
  • 3尹洪芳,李挺,李竞贤.应用世界卫生组织淋巴组织肿瘤新分类对304例恶性淋巴瘤的重新评估[J].中华医学杂志,2003,83(18):1556-1560. 被引量:36
  • 4Ohshima K, Suzumiya J, Sato K, et al. B-cell lymphoma of 708 cases in Japan: incidence rates and clinical prognosis according to the REAL classification. Cancer Lett, 1999,135:73-81.
  • 5[No authous listed]. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 1997,89:3909 -3918.
  • 6张素娟,赵彤,董敬朋,赵菲,邱红明,朱梅刚.石蜡切片DNA提取方法的改良及其临床应用[J].临床与实验病理学杂志,1996,12(4):363-364. 被引量:10
  • 7Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood, 2003,101:78-84.
  • 8蒋会勇,李海军,韩西群,贺莉,赵彤.PCR试验加样过程中无DNA原则控制污染的探讨[J].诊断病理学杂志,2005,12(1):45-48. 被引量:4
  • 9Tsujimoto Y, Gorham J, Cossman J, et al. The t ( 14; 18 ) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 1985,229:1390-1393.
  • 10Hill ME, MacLennan KA, Cunningham DC, et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood, 1996,88:1046-1051.

二级参考文献22

  • 1季卉,朱梅刚,赵彤,张素娟,董敬朋.多聚酶链反应技术在NHL基因诊断中的应用研究[J].中华病理学杂志,1994,23(4):207-210. 被引量:8
  • 2Yuan R,Br J Cancer,1993年,76卷,922页
  • 3Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of betaglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia[ J ]. Science, 1985,230 (4732): 1350 - 1354.
  • 4Van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936[ J]. Leukemia, 2003,17(12) :2257 - 2317.
  • 5Sarkar G, Sommer SS. Shedding light on PCR contamination [ J]. Nature, 1990,343(6253) :27.
  • 6Kwok S, Higuchi R. Avoiding false positives with PCR [ J ]. Nature,1989,339(6221): 237 - 238.
  • 7Thornton CG, Hartley JL, Rashtchian A. Utilizing uracil DNA glycosylase to control carryover contamination in PCR: characterization of residual UDG activity following thermal cycling [ J ]. Biotechniques,1992,13(2) :180 - 184.
  • 8Naresh KN, Srinivas V, Soman S. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R. E. A. L and WHO Classifications. Ann Oncol, 2000, 11: S63-67.
  • 9Lee SS, Cho K J, Kim CW, et al. The clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.Histopathology, 1999,35:345-354.
  • 10Chuang SS, Lin CN, Li CY. Malignant lympboma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer, 2000, 89: 1586-1592.

共引文献49

同被引文献23

  • 1冯文莉,黄宗干.B细胞非霍奇金淋巴瘤bcl-2/JH融合基因的检测及临床意义[J].中华血液学杂志,1997,18(7):361-363. 被引量:3
  • 2Lossos IS,Morgensztern D.Prognostic biomarkers in diffuse large B-cell lymphoma.J Clin Oncol,2006,24(6):995-1007.
  • 3Wu G,Keating A.Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma.Cancer,2006,106 (2):247-257.
  • 4Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood,2004,103 (1):275-282.
  • 5Shipp MA,Ross KN,Tamayo P,et al.Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.Nat Med,2002,8(1):68-74.
  • 6Lossos IS,Czerwinski DK,Alizadeh AA,et al.Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.N Engl J Med,2004,350(18):1828-1837.
  • 7Muris J,Meijer C,Vos W,et al.Immunohistochemical profiling based on bcl-2,CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.J Pathol,2006,208(5):714-723.
  • 8Berglund M,Thunberg U,Amini RM,et al.Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.Mod Pathol,2005,18 (8):1113-1120.
  • 9Jiang HY,Zhang SQ,Zhao T.A New Method to Make Nuclei or Cell Microarrays.Diagn Mol Pathol,2006,15 (2):109-114.
  • 10Kusumoto S,Kobayashi Y,Sekiguchi N,et al.Diffuse large Bcell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".Am J Surg Pathol,2005,29(8):1067-1073.

引证文献1

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部